Ready 4 Action is the four-step process used to evaluate the viability of proposed drug products. This important tool enables clients to make the go/no-go decision regarding a given drug's market potential and clinical development feasibility.
Armed with the neccessary intelligence, uncover with Ready 4 Action — including details of key factors influencing the pharmaceutical marketplace, the regulatory status and the clinical strategy involved in development of a specific drug — clients can make well-informed drug development decisions and avoid unnecessary and potentially destructive financial risks.
Camargo's Ready 4 Action assessment includes detailed data pertaining to your specific drug, along with a proposed clinical development plan — an invaluable feature of the assessment — and a schematic of the proposed plan. Incorporating major decision points and cost estimates, your plan includes clinical pharmacology, preclinical studies, pharmacokinetics and regulatory recommendations — that’s why it is a critical first step in the race to drug approval.
Ready 4 Action Product Planning Service Assessment:
Manufacturer Camargo Pharmaceutical Services
Be the first to review this product